Lung cancer is one of the most deadly types of cancers in the United States as well as around the world. As most of the therapies have been ineffective, this leaves patients…
Month: December 2022
U.S. FDA Approves Lung Cancer Drug, Adagrasib
The US Food and Drug Administration (FDA) has granted accelerated approval for Mirati Therapeutics’ Krazati (adagrasib) for treatment of mutated locally advanced or metastatic non-small cell lung cancer in adults. This accelerated…
Breathe Test to Detect Lung Cancer, Scientists Suggests
Lung cancer is one of the most common types of cancers all around the world and has the highest death rate. The reason behind high death rate is that it is often…
How to Cope Up With Fear of Recurrence Of Lung Cancer
When the treatment for lung cancer begins, the patients eagerly wait for the completion. But, one of the most common issues being faced by lung cancer survivors is the fear of recurrence…